FDA Grants Orphan Drug Designation for Mithridion's MCD-386CR to Treat Progressive Supranuclear Palsy
MADISON, Wis., May 9, 2011 /PRNewswire/ -- Mithridion, Inc., a privately-owned clinical stage drug development company focusing on serious Central Nervous System (CNS) disorders, announces that the U.S. Food and Drug Administration (FDA) has awarded Orphan Drug designation for MCD-386CR, its lead drug candidate, for the treatment of Progressive Supranuclear Palsy (PSP). Orphan status entitles ...
Sony PSP go Piano Black Handheld System
 | US $81.00 (39 Bids) End Date: Wednesday May-23-2012 8:03:21 PDT Bid now | Add to watch list |
Disclaimer: This site is a paid affiliate of eBay.com
Read more on redOrbit